Bajaj Healthcare Limited — Updates, 16-01-2026: Press Release
16-01-2026 | 09:28 pm
16-01-2026 | 09:28 pm
Bajaj Healthcare's Q3 revenue surged 31% to ₹161.22 Cr, with EBITDA up 35% to ₹32.33 Cr, powered by a 110% jump in API exports. The company also secured approval for new drug trials and launched a key CNS product, strengthening its portfolio.
No comments yet. Be the first to comment!
